Evidence map›Paper›PMID 33709055›Full record

ArticleAAS open research2021

Kenya's response to the COVID-19 pandemic: a balance between minimising morbidity and adverse economic impact.

Edwin N Wangari, Peter Gichuki, Angelyne A Abuor, Jacqueline Wambui, Stephen O Okeyo, Henry T N Oyatsi, Shadrack Odikara, Benard W Kulohoma

Abstract read
In one paragraph

Article in AAS open research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Edwin N WangariCentre for Biotechnology and Bioinformatics, University of Nairobi, Nairobi, Kenya.ORCID https://orcid.org/0000-0002-8338-0648
Peter GichukiCentre for Biotechnology and Bioinformatics, University of Nairobi, Nairobi, Kenya.ORCID https://orcid.org/0000-0003-1087-3916
Angelyne A AbuorCentre for Biotechnology and Bioinformatics, University of Nairobi, Nairobi, Kenya.
Jacqueline WambuiCentre for Biotechnology and Bioinformatics, University of Nairobi, Nairobi, Kenya.
Stephen O OkeyoCentre for Biotechnology and Bioinformatics, University of Nairobi, Nairobi, Kenya.
Henry T N OyatsiCentre for Biotechnology and Bioinformatics, University of Nairobi, Nairobi, Kenya.
Shadrack OdikaraCentre for Biotechnology and Bioinformatics, University of Nairobi, Nairobi, Kenya.ORCID https://orcid.org/0000-0003-4197-9713
Benard W KulohomaCentre for Biotechnology and Bioinformatics, University of Nairobi, Nairobi, Kenya.ORCID https://orcid.org/0000-0001-6825-1832

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19) has ravaged the world's socioeconomic systems forcing many governments across the globe to implement unprecedented stringent mitigation measures to restrain its rapid spread and adverse effects. A disproportionate number of COVID-19 related morbidities and mortalities were predicted to occur in Africa. However, Africa still has a lower than predicted number of cases, 4% of the global pandemic burden. In this open letter, we highlight some of the early stringent countermeasures implemented in Kenya, a sub-Saharan African country, to avert the severe effects of the COVID-19 pandemic. These mitigation measures strike a balance between minimising COVID-19 associated morbidity and fatalities and its adverse economic impact, and taken together have significantly dampened the pandemic's impact on Kenya's populace.

Indexed as

COVID-19disease control measuresKenyapandemic responsetransmission

Identifiers

PMID33709055
PMCPMC7921885.2

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.